Invention Grant
- Patent Title: Integrated molecular diagnostics system (iMDx) and method for dengue fever
-
Application No.: US16380693Application Date: 2019-04-10
-
Publication No.: US11446667B2Publication Date: 2022-09-20
- Inventor: Luke P. Lee , Jun Ho Sun
- Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Agency: O'Banion & Ritchey LLP
- Agent John P. O'Banion
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; B01L3/00 ; C12N5/078 ; C12Q1/686 ; C12Q1/6834 ; C12Q1/70 ; B01L7/00
Abstract:
An integrated molecular diagnostics system (iMDx) for the detection of Dengue Fever at point-of-care, wherein blood plasma separation for the selective separation of the Dengue virus from the whole blood, LED-driven photothermal lysis of the Dengue virus for the RNA extraction, and LED-driven rapid optical cavity PCR for the amplification of Dengue viral RNA are integrated on-chip within a single micro-fluidic device.
Public/Granted literature
- US20190299207A1 INTEGRATED MOLECULAR DIAGNOSTICS SYSTEM (IMDX) AND METHOD FOR DENGUE FEVER Public/Granted day:2019-10-03
Information query
